Immuron (IMRN) Current Taxes (2022 - 2023)
Immuron (IMRN) posted quarterly Current Taxes of $948.25 for Q4 2023, down 86.34% year-over-year from $6942.9 in Q4 2022, and down 99.79% quarter-over-quarter from $457652.7 in Q3 2023.
Immuron (IMRN) Current Taxes (2022 - 2023) Analysis & Trends
Immuron's Current Taxes history runs 2 years deep, the most recent figure standing at $948.25 for Q4 2023.
- In Q4 2023, Current Taxes fell 86.34% year-over-year to $948.25; the TTM figure through Dec 2023 stood at $948.25 (down 86.34% YoY), while the FY2023 annual figure was $6982.0, up 0.56% from the prior year.
- Current Taxes for Q4 2023 stood at $948.25, down from $457652.7 in the prior quarter.
- The five-year high for Current Taxes was $457652.7 in Q3 2023, with the low at $948.25 in Q4 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | 49.00 Mn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 76.32 Mn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | - |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | - |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | - |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 76.36 Mn |
| 10 | Immuron | 6.81 Mn | 6.78 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | 948.25 |
| Sep 28, 2023 | 457,652.70 |
| Aug 30, 2023 | 6,981.95 |
| Jun 30, 2023 | 4,666.46 |
| Dec 31, 2022 | 6,942.94 |